Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tilray Inc (TSX: TLRY )

6.550 +0.290 (+4.63%)
Streaming Delayed Price Updated: 3:47 PM EDT, May 17, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,513,307
Open 6.410
Bid (Size) 6.540 (57)
Ask (Size) 6.550 (97)
Prev. Close 6.260
Today's Range 6.290 - 6.620
52wk Range 5.080 - 27.88
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Global CBD Skin Care Market Size Anticipated To Reach $3.4 Billion By 2026, With A CAGR Of 24.80%
Palm Beach, FL –December 21, 2021 – FinancialNewsMedia.com News Commentary – The rise in consumer knowledge toward CBD infused FMCG product and ready product availability is anticipated to increase the... 
Via FinancialNewsMedia
Topics Cannabis Derivatives
Exposures Cannabis Derivatives
Tilray Continues Expanding Its Presence In Europe – Chosen To Supply Luxembourg's Medical Cannabis Program
Tilray, Inc. (TSX:TLRY) (NASDAQ: 
Via Benzinga
Topics Cannabis
Exposures Cannabis

Performance

YTD
-27.78%
-27.78%
1 Month
-9.53%
-9.53%
3 Month
-23.48%
-23.48%
6 Month
-59.77%
-59.77%
1 Year
-64.21%
-64.21%

More News

Read More
Tilray Expands Medical Cannabis Footprint in Europe
From Tilray, Inc.
Via Business Wire
Global CBD Market Retail Sales Jump Along With Rising Consumer Acceptance
Via FinancialNewsMedia
Topics Cannabis
Exposures Cannabis
Tilray Signs Distribution Agreement With Great North Distributors for Adult-Use Cannabis Sales Across Canada
From Tilray, Inc.
Via Business Wire
Medical Cannabis Market Anticipated to Reach $33.2 Billion By 2027
Via FinancialNewsMedia
Topics Cannabis Derivatives
Exposures Cannabis Derivatives
Tilray Strengthens Leadership Position in Canada
From Tilray, Inc.
Via Business Wire
Rise In Demand For Cannabis Is Expected To Continue Through 2027 Driving the Cultivation Industry
Via FinancialNewsMedia
Topics Cannabis
Exposures Cannabis
Tilray, Inc. Reports First Quarter Fiscal Year 2022 Financial Results
From Tilray, Inc.
Via Business Wire
Tilray to Announce First Quarter Fiscal 2022 Financial Results on October 7, 2021
From Tilray, Inc.
Via Business Wire
Cannabidiol Market Size Passed $7 Billion In 2020, Estimated To Grow At Over 35% CAGR Between 2021 And 2027
Via FinancialNewsMedia
Topics Cannabis
Exposures COVID-19 Cannabis
Tilray Stockholders Approve Proposal to Increase Authorized Shares at Special Meeting
From Tilray, Inc.
Via Business Wire
Tilray to Participate in Barclays Global Consumer Staples Conference on September 10th, 2021
From Tilray, Inc.
Via Business Wire
Hemp Fiber Market Projected To Reach $43.75 Billion By 2027
Via FinancialNewsMedia
Topics Cannabis
Exposures Cannabis Textiles
Tilray Chairman and CEO, Irwin D. Simon, Sends Shareholder Letter Mapping out $4B Revenue Plan
From Tilray, Inc.
Via Business Wire
Rising Awareness Of Health Benefits Of “Minor” Cannabinoids Such As CBG, CBDa CBC, CBN Driving U.S. Market
Via FinancialNewsMedia
Tilray Announces Adjournment of Special Meeting of Stockholders to September 10, 2021
From Tilray, Inc.
Via Business Wire
Tilray Acquires Majority Position in Amended MedMen Convertible Notes, Accelerating Tilray's Path Into U.S. Cannabis Market When, Not If, Federal Legalization Occurs
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Acquires Majority Position in Amended MedMen Convertible Notes
From Tilray, Inc.
Via Business Wire
Tilray Launches New Medical Cannabis Edibles in Canada
From Tilray, Inc.
Via Business Wire
Tilray Announces Adjournment of Special Meeting of Stockholders to August 19, 2021
From Tilray, Inc.
Via Business Wire
Global Cannabidiol Market Size Expected to Reach $2.8 Billion by 2028 with a CAGR of 21%
Via FinancialNewsMedia
Topics Cannabis
Exposures Cannabis
Tilray, Inc. Reports 2021 Fiscal Year and Fourth Quarter Results
From Tilray, Inc.
Via Business Wire
CIBC Continues To Downgrade The Canadian Cannabis Sector
Via Talk Markets
Topics Cannabis
Exposures Cannabis
CBD Product Sales Could Reach Nearly $17 Billion Dollars In The U.S. Alone By 2025
Via FinancialNewsMedia
Topics Cannabis
Exposures COVID-19 Cannabis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.